-

NYSE: INSP Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Inspire Medical Systems, Inc. (NYSE: INSP) Investors With Significant Losses to Contact the Firm

RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”).

On August 4, 2025, Inspire issued a press release announcing its second quarter financial results and updating its 2025 outlook. Among other items, Inspire reduced its full-year revenue outlook and diluted net income per share. Inspire attributed the reductions to slower-than-expected progress of the commercial launch of its next generation “Inspire V” neurostimulation system.

On this news, Inspire’s stock price fell $42.04 per share, or 32.35%, to close at $87.91 per share on August 5, 2025.

If you are an Inspire investor and would like to learn more about our investigation, please CLICK HERE to fill out our online form or contact Kessler Topaz Meltzer & Check, LLP: Jonathan Naji, Esq. (484) 270-1453 or E-mail at info@ktmc.com. You can also click on the following link or paste it in your browser: https://www.ktmc.com/inspire-medical-systems-inc-investigation?utm_source=Businesswire&mktm=PR

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.

May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.

Contacts

Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
280 King of Prussia Road
Radnor, PA 19087
(484) 270-1453
info@ktmc.com

Kessler Topaz Meltzer & Check, LLP

NYSE:INSP

Release Versions

Contacts

Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
280 King of Prussia Road
Radnor, PA 19087
(484) 270-1453
info@ktmc.com

More News From Kessler Topaz Meltzer & Check, LLP

NYSE: KMX: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against CarMax, Inc.

RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against CarMax, Inc. (“CarMax”) (NYSE: KMX) on behalf of those who purchased or otherwise acquired CarMax securities between June 20, 2025, and September 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is January 2, 2026. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered CarMax losses, you...

NASDAQ: QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V. (NASDAQ: QURE) (“uniQure”). On November 3, 2025, uniQure issued a press release revealing that the FDA notified the company that data for its AMT-130, an investigational gene therapy for Huntington’s disease, did not provide sufficient evidence to support uniQure’s Biologics Licen...

JHX Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against James Hardie Industries plc.

RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against James Hardie Industries plc (“James Hardie”) (NYSE: JHX) on behalf of those who purchased or otherwise acquired James Hardie common stock between May 20, 2025, and August 18, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is December 23, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you s...
Back to Newsroom